AXIOM EVIDENCE BRIEF

Protocol Findings™

This briefing summarises recurring findings within peer-reviewed literature examining recovery biology, mitochondrial signalling, inflammatory modulation, extracellular matrix remodelling, and telomere dynamics. Emphasis is placed on mechanistic consistency, reproducibility in preclinical models, and areas where current scientific understanding remains limited.
Across multiple areas of peptide research, the strongest evidence typically emerges from mechanistic studies conducted within in-vitro systems and animal models. These environments allow researchers to isolate specific signalling pathways and observe how defined peptide sequences influence cellular behaviour.
The findings summarised below highlight recurring patterns within the literature and identify the biological mechanisms most frequently observed in controlled experimental studies.

Recovery Protocol™

Mechanistic Strength & Research Consensus

BPC-157

Research conducted by Professor Predrag Sikiric and colleagues at the University of Zagreb between 2010 and 2016 examined the peptide BPC-157 within experimental models of vascular injury and endothelial signalling. Publications appearing in journals including Journal of Molecular Medicine, Current Pharmaceutical Design, and Peptides explored how the compound influenced angiogenic pathways and vascular repair mechanisms.
In vitro endothelial studies demonstrated that BPC-157 exposure increased migration and tube formation within cultured endothelial cells, suggesting enhanced angiogenic signalling capacity. These effects were associated with activation of signalling pathways involving vascular endothelial growth factor receptor 2 (VEGFR2), Akt phosphorylation, and endothelial nitric oxide synthase (eNOS) activity.
Animal models examining tendon and vascular injury also demonstrated improved endothelial stability markers and increased nitric-oxide-related signalling. Several studies reported that BPC-157 appeared to influence the nitric oxide system by modulating both endothelial nitric oxide synthase activity and prostaglandin-related signalling pathways.
Key studies:
Sikiric et al., Journal of Molecular Medicine, 2013
Sikiric et al., Current Pharmaceutical Design, 2016
Sikiric et al., Peptides, 2010
Strongest Findings
Increased endothelial cell migration in vitro
Enhanced tube formation within extracellular matrix assays
Activation of VEGFR2 → Akt → eNOS signalling pathways
Modulation of nitric oxide–related vascular signalling
Evidence Context
The majority of findings originate from rodent injury models and cellular assays. Large-scale human clinical data examining BPC-157 remain limited.

Thymosin β4 (TB-500)

Thymosin β4 has been extensively investigated for its role in cytoskeletal regulation and cellular migration. Early research from George Washington University and collaborative laboratories examined the peptide’s interaction with actin polymerisation and its role in wound repair processes.
Goldstein and colleagues demonstrated that Thymosin β4 acts as a G-actin sequestration molecule, influencing cytoskeletal reorganisation and facilitating cellular movement. Studies published in The Journal of Investigative Dermatology and Annals of the New York Academy of Sciences reported accelerated wound closure rates in rodent dermal injury models when Thymosin β4 was introduced into experimental systems.
Scratch assay models used in vitro showed increased fibroblast and keratinocyte migration following exposure to the peptide. These findings suggest that Thymosin β4 influences actin filament dynamics and promotes cellular movement across damaged tissue surfaces.
Additional studies have indicated that Thymosin β4 may also influence inflammatory signalling pathways during early phases of tissue repair, particularly through modulation of macrophage infiltration in wound environments.
Key studies:
Goldstein et al., Annals of the New York Academy of Sciences, 2007
Malinda et al., The Journal of Investigative Dermatology, 1999
Huff et al., The Journal of Cell Biology, 2001
Strongest Findings
Regulation of cytoskeletal dynamics through G-actin binding
Increased cellular migration in wound-healing assays
Accelerated epithelial closure in dermal injury models
Evidence Context
Strong mechanistic evidence exists within dermal and tissue migration models. Evidence outside these contexts remains more limited.

GHK-Cu

GHK-Cu is a naturally occurring copper-binding tripeptide first identified by Dr. Loren Pickart in the 1970s. Research published in Biochemical Pharmacology in 1988 demonstrated that the peptide significantly increased collagen synthesis in cultured human fibroblasts.
Subsequent research expanded investigation into the peptide’s role in extracellular matrix remodelling and tissue regeneration biology. Studies showed that GHK-Cu may influence fibroblast activity, stimulate collagen and glycosaminoglycan synthesis, and modulate expression of metalloproteinases involved in extracellular matrix turnover.
Additional investigations have suggested that the peptide may possess antioxidant properties through copper-dependent enzyme activity, influencing pathways associated with oxidative stress regulation in dermal tissues.
Key studies:
Pickart et al., Biochemical Pharmacology, 1988
Pickart & Margolina, Journal of Aging Research, 2012
Strongest Findings
Increased collagen synthesis in human fibroblast cultures
Enhanced extracellular matrix remodelling markers
Modulation of oxidative stress signalling in dermal systems
Evidence Context
Evidence is strongest in fibroblast and dermatological research environments.

Cellular Fundamentals™

Metabolic & Signalling Evidence

NAD+

Nicotinamide adenine dinucleotide (NAD+) is one of the most extensively studied molecules in cellular metabolism. Its role as a coenzyme in redox reactions has been documented for more than a century, and modern research has highlighted its importance in mitochondrial function, DNA repair, and metabolic regulation.
NAD+ functions as a required substrate for several enzyme families including sirtuins, poly-ADP-ribose polymerases (PARPs), and CD38 enzymes. These proteins regulate processes ranging from DNA repair to mitochondrial biogenesis.
Research published in Cell, Nature Reviews Molecular Cell Biology, and Science has shown that NAD+ levels decline with age in multiple biological models. Experimental restoration of NAD+ levels in animal models has been associated with improved mitochondrial signalling, enhanced oxidative metabolism, and increased activity of sirtuin-dependent pathways.
Key studies:
Yoshino et al., Cell Metabolism, 2011
Verdin, Science, 2015
Imai & Guarente, Nature Reviews Molecular Cell Biology, 2014
Strongest Findings
Essential cofactor in mitochondrial metabolism and redox reactions
Activation of sirtuin signalling pathways
Age-associated decline observed across multiple biological models
Evidence Context
Biochemical function is well established. The extent to which NAD+ modulation influences ageing in humans remains an area of active research.

MOTS-c

MOTS-c is a mitochondrial-derived peptide first identified by Changhan Lee and colleagues at the University of Southern California. The discovery was published in Cell Metabolism in 2015 and demonstrated that mitochondria encode short peptides capable of functioning as metabolic signalling molecules.
Experimental studies showed that MOTS-c can translocate to the cell nucleus during metabolic stress and influence gene expression involved in adaptive metabolism. One of the key mechanisms observed involves activation of the AMP-activated protein kinase (AMPK) pathway, a central regulator of energy homeostasis.
In murine models, administration of MOTS-c improved metabolic parameters under conditions of diet-induced obesity and increased insulin sensitivity markers.
Key study:
Lee et al., Cell Metabolism, 2015
Strongest Findings
Identification as a mitochondrial-encoded signalling peptide
Activation of AMPK metabolic pathways
Improved metabolic stress response in animal models
Evidence Context
Mechanistic evidence is compelling but human translational data remain limited.

KPV

KPV is a tripeptide fragment derived from alpha-melanocyte stimulating hormone. Research examining the peptide has focused primarily on its potential influence on inflammatory signalling pathways.
Studies published in The Journal of Immunology have shown that KPV may suppress activation of nuclear factor kappa-B (NF-κB), a transcription factor that regulates expression of inflammatory cytokines.
Experimental models of inflammatory bowel disease in mice demonstrated reduced inflammatory cytokine production and decreased tissue inflammation following exposure to the peptide.
Key studies:
Getting et al., The Journal of Immunology, 2003
Gonzalez-Rey et al., The Journal of Immunology, 2006
Strongest Findings
Inhibition of NF-κB signalling
Reduction of pro-inflammatory cytokine expression
Improved inflammatory markers in murine models
Evidence Context
Research has primarily focused on gastrointestinal inflammatory systems.

AOD9604

AOD9604 is a modified fragment of human growth hormone originally investigated by researchers at Monash University. Early studies explored the peptide’s potential role in lipid metabolism through interaction with adipose tissue signalling pathways.
Experimental rodent studies demonstrated that the peptide stimulated lipolysis through beta-3 adrenergic receptor signalling while avoiding many of the systemic endocrine effects associated with full growth hormone molecules.
Clinical trials conducted in the early 2000s produced mixed results in human obesity studies, and pharmaceutical development was eventually discontinued despite encouraging animal model data.
Key studies:
Ng et al., Endocrinology, 2001
Heffernan et al., Obesity Research, 2001
Strongest Findings
Lipolytic activity in rodent adipose tissue models
Activation of β3-adrenergic receptor pathways
Evidence Context
Animal model findings stronger than human clinical outcomes.

Longevity Protocol™

Telomere & Adaptive Signalling Research

Epitalon

Epitalon is a synthetic tetrapeptide derived from the natural pineal peptide epithalamin. Research conducted at the St. Petersburg Institute of Bioregulation and Gerontology in Russia examined its potential influence on telomerase activity and chromosomal stability.
Experimental studies published in Biogerontology and related journals reported that Epitalon exposure increased telomerase activity in cultured human somatic cells and was associated with elongation of telomere markers within experimental environments.
Animal studies investigating lifespan effects in rodents produced observations suggesting improved survival metrics under certain experimental conditions, though interpretation of these findings remains debated.
Key studies:
Khavinson et al., Biogerontology, 2003
Anisimov et al., Neuroendocrinology Letters, 2001
Strongest Findings
Increased telomerase activity observed in cell culture
Telomere length markers influenced in experimental models
Evidence Context
Mechanistic research remains largely preclinical and requires further clinical investigation.

Measured Evidence Context

Evidence Hierarchy & Interpretation

The findings summarised above reflect patterns observed within peer-reviewed scientific literature. Most peptide research currently exists within preclinical environments including cellular assays and animal models.
While these systems provide valuable insight into molecular mechanisms, translation of findings to human physiology requires careful evaluation through controlled clinical research.
These summaries are presented for scientific reference only.

NOT FOR HUMAN CONSUMPTION

NOT FOR MEDICAL USE

SUPPLIED FOR IN-VITRO RESEARCH

COMPLIANCE ENFORCED

Precision in supply. Discipline in research.

Defined standards without compromise.